DANIEL ANSARI

affiliated with the university
More filtering options
  1. Acute pancreatitis - costs for healthcare and loss of production.

    Bodil Andersson, Appelgren, B., Sjödin, V., Daniel Ansari, Johan Nilsson, Persson, U., Bobby Tingstedt & Roland Andersson, 2013, In : Scandinavian Journal of Gastroenterology. 48, 12, p. 1459-1465

    Research output: Contribution to journalArticle

  2. Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis

    Q. Zhou, Roland Andersson, Dingyuan Hu, Bauden, M., Sasor, A., Bygott, T., Krzysztof PawŁowski, Pla, I., György Marko-Varga & Daniel Ansari, 2019 Jun 29, In : Translational Research. 212, p. 67-79 13 p.

    Research output: Contribution to journalArticle

  3. Analysis of MUC4 Expression in Human Pancreatic Cancer Xenografts in Immunodeficient Mice.

    Daniel Ansari, Bauden, M., Sasor, A., Gundewar, C. & Roland Andersson, 2014, In : Anticancer research. 34, 8, p. 3905-3910

    Research output: Contribution to journalArticle

  4. Apicidin Sensitizes Pancreatic Cancer Cells to Gemcitabine by Epigenetically Regulating MUC4 Expression.

    Daniel Ansari, Urey, C., Said Hilmersson, K., Bauden, M., Fredrik Ek, Roger Olsson & Roland Andersson, 2014, In : Anticancer research. 34, 10, p. 5269-5276

    Research output: Contribution to journalArticle

  5. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma

    Dingyuan Hu, Daniel Ansari, Qimin Zhou, Sasor, A., Hilmersson, K. S., Bauden, M., Jiang, Y. & Roland Andersson, 2018 Nov 12, In : BMC Cancer. 18, 1, 1 p.

    Research output: Contribution to journalArticle

  6. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?

    Daniel Ansari, Sambergs, F., Johansson, L. & Roland Andersson, 2017, In : Expert Review of Proteomics. 14, 6, p. 469-471 3 p.

    Research output: Contribution to journalDebate/Note/Editorial

  7. Centrosomal Abnormalities in Pancreatic Cancer: Molecular Mechanisms and Clinical Implications

    Daniel Ansari, Del Pino Bellido, C., Bauden, M. & Roland Andersson, 2018 Mar 1, In : Anticancer research. 38, 3, p. 1241-1245

    Research output: Contribution to journalReview article

  8. Chronic pancreatitis: potential future interventions.

    Daniel Ansari, Andersson, E., Bodil Andersson & Roland Andersson, 2010, In : Scandinavian Journal of Gastroenterology. 45, 9, p. 1022-1028

    Research output: Contribution to journalReview article

  9. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.

    Bauden, M., Pamart, D., Daniel Ansari, Herzog, M., Eccleston, M., Micallef, J., Bodil Andersson & Roland Andersson, 2015, In : Clinical Epigenetics. 7, 106.

    Research output: Contribution to journalArticle

  10. Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases.

    Daniel Ansari, Urey, C., Gundewar, C., Bauden, M. & Roland Andersson, 2013, In : Scandinavian Journal of Gastroenterology. 48, 10, p. 1183-1187

    Research output: Contribution to journalArticle

  11. Diagnosis and management of duodenal perforations: a narrative review

    Daniel Ansari, William Torén, Lindberg, S., Pyrhönen, H-S. & Roland Andersson, 2019, In : Scandinavian Journal of Gastroenterology. 54, 8, p. 939-944

    Research output: Contribution to journalReview article

  12. Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

    Sun, C., Daniel Ansari, Roland Andersson & Wu, D-Q., 2012, In : World Journal of Gastroenterology. 18, 35, p. 4944-4958

    Research output: Contribution to journalArticle

  13. Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?

    Linus Aronsson, Roland Andersson, Swahn, F. & Daniel Ansari, 2017 Oct 3, In : Scandinavian Journal of Gastroenterology. 52, 10, p. 1049-1051 3 p.

    Research output: Contribution to journalReview article

  14. Early-onset pancreatic cancer: a population-based study using the SEER registry

    Daniel Ansari, Althini, C., Ohlsson, H. & Roland Andersson, 2019, In : Langenbeck's Archives of Surgery. 404, 5, p. 565-571 7 p.

    Research output: Contribution to journalArticle

  15. Early postoperative fluid retention is a strong predictor for complications after pancreatoduodenectomy

    Åkerberg, D., Daniel Ansari, Magnus Bergenfeldt, Roland Andersson & Bobby Tingstedt, 2019 Dec, In : HPB. 21, 12, p. 1784-1789 5 p.

    Research output: Contribution to journalArticle

  16. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma

    Syren, P., Roland Andersson, Bauden, M. & Daniel Ansari, 2017 Jul 3, In : Scandinavian Journal of Gastroenterology. 52, 6-7, p. 668-673

    Research output: Contribution to journalReview article

  17. Fast-track programmes for hepatopancreatic resections: where do we stand?

    Lidewij Spelt, Daniel Ansari, Sturesson, C., Bobby Tingstedt & Roland Andersson, 2011, In : HPB. 13, 12, p. 833-838

    Research output: Contribution to journalArticle

  18. Fast-track surgery: procedure-specific aspects and future direction.

    Daniel Ansari, Gianotti, L., Schröder, J. & Roland Andersson, 2012, In : Langenbeck's Archives of Surgery.

    Research output: Contribution to journalArticle

  19. Hemorrhage after Major Pancreatic Resection: Incidence, Risk Factors, Management, and Outcome.

    Daniel Ansari, Bobby Tingstedt, Lindell, G., Keussen, I., Ansari, D. & Roland Andersson, 2017, In : Scandinavian Journal of Surgery. 106, 1, p. 47-53

    Research output: Contribution to journalArticle

  20. Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

    Bauden, M., Kristl, T., Sasor, A., Bodil Andersson, György Marko-Varga, Roland Andersson & Daniel Ansari, 2017 Dec 2, In : BMC Cancer. 17, 1, 810.

    Research output: Contribution to journalArticle

  21. Immune checkpoint therapy for pancreatic cancer

    Johansson, H., Roland Andersson, Bauden, M., Hammes, S., Holdenrieder, S. & Daniel Ansari, 2016 Nov 21, In : World Journal of Gastroenterology. 22, 43, p. 9457-9476 20 p.

    Research output: Contribution to journalReview article

  22. Is immunotherapy the holy grail for pancreatic cancer?

    Roland Andersson, Carlos Filipe Pereira, Bauden, M. & Daniel Ansari, 2019, In : Immunotherapy. 11, 17, p. 1435-1438 4 p.

    Research output: Contribution to journalDebate/Note/Editorial

  23. Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer

    Dingyuan Hu, Daniel Ansari, Qimin Zhou, Sasor, A., Hilmersson, K. S. & Roland Andersson, 2019, In : Scandinavian Journal of Gastroenterology. 54, 2, p. 246-251 6 p.

    Research output: Contribution to journalArticle

  24. Neoadjuvant/Downstaging Radiochemotherapy in Marginally Resectable Pancreatic Cancer

    Daniel Ansari, Kervinen, M. & Roland Andersson, 2014, In : Hepato-Gastroenterology. 61, 136, p. 2387-2390

    Research output: Contribution to journalArticle

  25. Pancreatic cancer: Yesterday, today and tomorrow

    Daniel Ansari, Bobby Tingstedt, Bodil Andersson, Fredrik Holmquist, Sturesson, C., Caroline Williamsson, Sasor, A., David Borg, Bauden, M. & Roland Andersson, 2016 Aug 1, In : Future Oncology. 12, 16, p. 1929-1946 18 p.

    Research output: Contribution to journalArticle

  26. Pancreatic cancer: Disease dynamics, tumor biology and the role of the microenvironment

    Daniel Ansari, Friess, H., Bauden, M., Samnegård, J. & Roland Andersson, 2018, In : Oncotarget. 9, 5, p. 6644-6651 8 p.

    Research output: Contribution to journalReview article

  27. Pancreatic cancer and thromboembolic disease, 150 years after Trousseau.

    Ansari, D., Daniel Ansari, Roland Andersson & Andrén-Sandberg, Å., 2015, In : Hepatobiliary surgery and nutrition. 4, 5, p. 325-335

    Research output: Contribution to journalReview article

Previous 1 2 Next